The Rheumatology Department of Sierrallana Hospital, in collaboration with the Clinical Trials Agency of the Valdecilla Health Research Institute (IDIVAL), has designed and launched a clinical trial aimed at optimizing the primary prevention of cardiovascular (CV) events in patients with inflammatory rheumatic diseases. The study, titled “Randomized clinical trial to assess the efficacy and safety […]
The Marqués de Valdecilla Research Institute (IDIVAL) held the forum “Advancing in Research,” a meeting aimed at patient associations that made it possible to share the main biomedical research projects being developed in Cantabria and to strengthen collaboration between scientists, healthcare professionals, and civil society. The event also served to present the progress of Cohorte […]
By 2040, 27% of the Spanish population will be over the age of 65, and life expectancy will have increased by three years compared to 2021. This progressive ageing will not only reshape the demographic structure but also significantly increase the prevalence of chronic diseases. In this context, the Valdecilla Health Research Institute (IDIVAL), firmly […]
The Marqués de Valdecilla Research Institute (IDIVAL) received the institutional visit of Núria Montserrat Pulido, Minister for Research and Universities of the Generalitat of Catalonia, as part of her trip to Cantabria to learn first-hand about the scientific activity carried out by various research centres linked to the University of Cantabria. During her visit to […]
Members of the Health Economics Group at the Marqués de Valdecilla Research Institute (IDIVAL) and the University of Cantabria (UC), participants in the European project “Intelligent Digital Twin for Social Prescribing in Primary Healthcare” (SAM, acronym for Health, Social, Assets and Map), aimed at improving healthcare and population well‑being and framed within the Interreg Sudoe […]
The European Network of Comprehensive Cancer Centres (EUnetCCC) has designated the 14 Comprehensive Cancer Centres (CCC) in Spain, marking an important step toward more coordinated, equitable, and accessible cancer care across Europe. The Joint Action has just announced the following centres as EU‑Designated CCCs: CCC Euskadi – Basque Country, Regional University Hospital of Málaga, Virgen […]
A scientific article co‑authored by David Peña Otero, researcher in the Nursing Group at the Marqués de Valdecilla Research Institute (IDIVAL), has analyzed the effectiveness of educational interventions aimed at hospitalized patients with chronic respiratory diseases. The study is a systematic review that examines the available scientific evidence on this type of intervention and its […]
The INN-VAL and DTEC-VAL calls, aimed at promoting innovation in the healthcare and scientific environment, will soon open their application periods. To present their features and requirements, an online informational meeting will be held on March 25. During the session, the most relevant aspects of both programs will be discussed, including the documentation required to […]
The Valdecilla Health Research Institute (IDIVAL) has awarded funding through its innovation support program (INNVAL) to a project led by researcher Raquel López, from the Immunopathology group. The project aims to improve the diagnosis and prognosis of IgA‑mediated vasculitis (IgAV), an inflammatory disease that poses a significant challenge in clinical practice, particularly due to its […]
From now on, the largest population cohort in southern Europe will integrate genomic and proteomic analysis into the clinical data of 50,000 volunteers from Cantabria, enabling it to truly attract investment and talent. ‘Cohorte Cantabria’ takes a crucial step today toward a model of medicine based on “precision, prevention, and anticipation,” which will make it […]
